US Stock MarketDetailed Quotes

MTNB Matinas BioPharma

Watchlist

0.1815
+0.0015+0.83%

Close Apr 23 16:00 ET

0.1830
+0.0015+0.83%

Post 19:54 ET

45.52MMarket Cap-1650P/E (TTM)

Matinas BioPharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

(Q1)Mar 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

20.24%-15.28M

-6.51%-4.58M

11.09%-4.42M

57.26%-2.19M

14.07%-4.09M

-25.84%-19.16M

-8.64%-4.3M

13.56%-4.97M

-493.42%-5.13M

-2.26%-4.76M

Net income from continuing operations

-9.26%-22.94M

-46.23%-5.31M

-10.86%-6.06M

-2.31%-6.06M

7.78%-5.51M

9.82%-21M

45.75%-3.63M

20.11%-5.46M

-23.62%-5.92M

-20.61%-5.98M

Operating gains losses

-50.00%1K

----

0.00%2K

----

Depreciation and amortization

4.79%941K

6.19%240K

3.48%238K

1.30%234K

8.53%229K

14.98%898K

10.45%226K

17.32%230K

26.38%231K

6.80%211K

Other non cash items

-78.69%107K

-67.92%17K

-64.58%17K

-40.82%29K

-87.50%44K

-65.38%502K

-31.85%53K

-96.20%48K

-9.78%49K

548.84%352K

Change In working capital

134.81%1.67M

65.22%-795K

115.43%185K

440.83%2.4M

80.20%-119K

-411.99%-4.79M

-265.31%-2.29M

16.37%-1.2M

-126.69%-703K

42.64%-601K

-Change in prepaid assets

194.90%3.98M

99.15%-13K

54.31%-286K

185.73%1.86M

1,883.61%2.42M

-410.89%-4.2M

-219.51%-1.52M

62.32%-626K

-260.61%-2.17M

-68.42%122K

-Change in payables and accrued expense

-2,336.11%-1.75M

0.79%-631K

240.64%616K

-58.20%668K

-303.86%-2.41M

-111.16%-72K

-371.37%-636K

-227.81%-438K

15.31%1.6M

54.78%-596K

-Change in other current liabilities

-8.08%-562K

-17.05%-151K

-7.41%-145K

-3.88%-134K

-3.94%-132K

-13.04%-520K

-3.89%-129K

-17.38%-135K

-23.40%-129K

-9.22%-127K

Cash from discontinued investing activities

Operating cash flow

20.24%-15.28M

-6.51%-4.58M

11.09%-4.42M

57.26%-2.19M

14.07%-4.09M

-25.84%-19.16M

-8.64%-4.3M

13.56%-4.97M

-493.42%-5.13M

-2.26%-4.76M

Investing cash flow

Cash flow from continuing investing activities

171.52%13.24M

7,147.62%2.96M

-81.15%1.08M

263.45%6.2M

1.32%3M

-70.92%4.88M

-174.14%-42K

2,269.23%5.75M

-149.54%-3.79M

-66.42%2.96M

Net PPE purchase and sale

75.56%-218K

--0

93.60%-16K

-267.27%-202K

--0

-243.08%-892K

-17.28%-42K

-11.51%-250K

---55K

---545K

Net investment purchase and sale

133.32%13.46M

--2.96M

-81.67%1.1M

271.26%6.4M

-14.43%3M

-66.12%5.77M

--0

1,185.12%6M

-148.83%-3.74M

-60.24%3.51M

Cash from discontinued investing activities

Investing cash flow

171.52%13.24M

7,147.62%2.96M

-81.15%1.08M

263.45%6.2M

1.32%3M

-70.92%4.88M

-174.14%-42K

2,269.23%5.75M

-149.54%-3.79M

-66.42%2.96M

Financing cash flow

Cash flow from continuing financing activities

-108.86%-7K

80.00%-1K

66.67%-1K

83.33%-1K

-104.30%-4K

-98.87%79K

-160.02%-5K

63.96%-3K

-103.32%-6K

-98.63%93K

Net issuance payments of debt

65.00%-7K

80.00%-1K

66.67%-1K

83.33%-1K

33.33%-4K

33.33%-20K

9.76%-5K

63.96%-3K

26.40%-6K

24.84%-6K

Proceeds from stock option exercised by employees

--0

-93.00%99K

--0

-91.83%99K

Cash from discontinued financing activities

Financing cash flow

-108.86%-7K

80.00%-1K

66.67%-1K

83.33%-1K

-104.30%-4K

-98.87%79K

-160.02%-5K

63.96%-3K

-103.32%-6K

-98.63%93K

Net cash flow

Beginning cash position

-66.73%7.08M

-41.74%6.66M

-6.16%9.99M

-69.41%5.99M

-66.73%7.08M

66.67%21.28M

-54.61%11.43M

-65.30%10.65M

-17.46%19.58M

66.66%21.28M

Current changes in cash

85.61%-2.04M

62.72%-1.62M

-529.34%-3.34M

144.84%4M

35.90%-1.09M

-266.82%-14.2M

-11.66%-4.35M

114.09%777K

-228.11%-8.93M

-115.54%-1.7M

End cash Position

-28.86%5.04M

-41.74%6.66M

-6.16%9.99M

-69.41%5.99M

-66.73%7.08M

-54.61%11.43M

-65.30%10.65M

-17.46%19.58M

Free cash flow

22.71%-15.5M

-5.48%-4.58M

15.04%-4.44M

53.82%-2.4M

22.90%-4.09M

-29.48%-20.05M

-8.71%-4.34M

12.62%-5.22M

-499.78%-5.19M

-13.97%-5.3M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022	(Q1)Mar 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	20.24%-15.28M	-6.51%-4.58M	11.09%-4.42M	57.26%-2.19M	14.07%-4.09M	-25.84%-19.16M	-8.64%-4.3M	13.56%-4.97M	-493.42%-5.13M	-2.26%-4.76M
Net income from continuing operations	-9.26%-22.94M	-46.23%-5.31M	-10.86%-6.06M	-2.31%-6.06M	7.78%-5.51M	9.82%-21M	45.75%-3.63M	20.11%-5.46M	-23.62%-5.92M	-20.61%-5.98M
Operating gains losses	-50.00%1K	----	----	----	----	0.00%2K	----	----	----	----
Depreciation and amortization	4.79%941K	6.19%240K	3.48%238K	1.30%234K	8.53%229K	14.98%898K	10.45%226K	17.32%230K	26.38%231K	6.80%211K
Other non cash items	-78.69%107K	-67.92%17K	-64.58%17K	-40.82%29K	-87.50%44K	-65.38%502K	-31.85%53K	-96.20%48K	-9.78%49K	548.84%352K
Change In working capital	134.81%1.67M	65.22%-795K	115.43%185K	440.83%2.4M	80.20%-119K	-411.99%-4.79M	-265.31%-2.29M	16.37%-1.2M	-126.69%-703K	42.64%-601K
-Change in prepaid assets	194.90%3.98M	99.15%-13K	54.31%-286K	185.73%1.86M	1,883.61%2.42M	-410.89%-4.2M	-219.51%-1.52M	62.32%-626K	-260.61%-2.17M	-68.42%122K
-Change in payables and accrued expense	-2,336.11%-1.75M	0.79%-631K	240.64%616K	-58.20%668K	-303.86%-2.41M	-111.16%-72K	-371.37%-636K	-227.81%-438K	15.31%1.6M	54.78%-596K
-Change in other current liabilities	-8.08%-562K	-17.05%-151K	-7.41%-145K	-3.88%-134K	-3.94%-132K	-13.04%-520K	-3.89%-129K	-17.38%-135K	-23.40%-129K	-9.22%-127K
Cash from discontinued investing activities
Operating cash flow	20.24%-15.28M	-6.51%-4.58M	11.09%-4.42M	57.26%-2.19M	14.07%-4.09M	-25.84%-19.16M	-8.64%-4.3M	13.56%-4.97M	-493.42%-5.13M	-2.26%-4.76M
Investing cash flow
Cash flow from continuing investing activities	171.52%13.24M	7,147.62%2.96M	-81.15%1.08M	263.45%6.2M	1.32%3M	-70.92%4.88M	-174.14%-42K	2,269.23%5.75M	-149.54%-3.79M	-66.42%2.96M
Net PPE purchase and sale	75.56%-218K	--0	93.60%-16K	-267.27%-202K	--0	-243.08%-892K	-17.28%-42K	-11.51%-250K	---55K	---545K
Net investment purchase and sale	133.32%13.46M	--2.96M	-81.67%1.1M	271.26%6.4M	-14.43%3M	-66.12%5.77M	--0	1,185.12%6M	-148.83%-3.74M	-60.24%3.51M
Cash from discontinued investing activities
Investing cash flow	171.52%13.24M	7,147.62%2.96M	-81.15%1.08M	263.45%6.2M	1.32%3M	-70.92%4.88M	-174.14%-42K	2,269.23%5.75M	-149.54%-3.79M	-66.42%2.96M
Financing cash flow
Cash flow from continuing financing activities	-108.86%-7K	80.00%-1K	66.67%-1K	83.33%-1K	-104.30%-4K	-98.87%79K	-160.02%-5K	63.96%-3K	-103.32%-6K	-98.63%93K
Net issuance payments of debt	65.00%-7K	80.00%-1K	66.67%-1K	83.33%-1K	33.33%-4K	33.33%-20K	9.76%-5K	63.96%-3K	26.40%-6K	24.84%-6K
Proceeds from stock option exercised by employees	--0	--0	--0	--0	--0	-93.00%99K	--0	--0	--0	-91.83%99K
Cash from discontinued financing activities
Financing cash flow	-108.86%-7K	80.00%-1K	66.67%-1K	83.33%-1K	-104.30%-4K	-98.87%79K	-160.02%-5K	63.96%-3K	-103.32%-6K	-98.63%93K
Net cash flow
Beginning cash position	-66.73%7.08M	-41.74%6.66M	-6.16%9.99M	-69.41%5.99M	-66.73%7.08M	66.67%21.28M	-54.61%11.43M	-65.30%10.65M	-17.46%19.58M	66.66%21.28M
Current changes in cash	85.61%-2.04M	62.72%-1.62M	-529.34%-3.34M	144.84%4M	35.90%-1.09M	-266.82%-14.2M	-11.66%-4.35M	114.09%777K	-228.11%-8.93M	-115.54%-1.7M
End cash Position	-28.86%5.04M	-28.86%5.04M	-41.74%6.66M	-6.16%9.99M	-69.41%5.99M	-66.73%7.08M	-66.73%7.08M	-54.61%11.43M	-65.30%10.65M	-17.46%19.58M
Free cash flow	22.71%-15.5M	-5.48%-4.58M	15.04%-4.44M	53.82%-2.4M	22.90%-4.09M	-29.48%-20.05M	-8.71%-4.34M	12.62%-5.22M	-499.78%-5.19M	-13.97%-5.3M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	Unqualified Opinion with Explanatory Notes	--	--	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall